Filter
2052
Filtered Results: 2052
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
228
New Publications
668
Language
Document type
No document type
1250
Guidelines
299
Studies & Reports
245
Manuals
112
Strategic & Response Plan
92
Training Material
21
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
131
Kenya
72
Global
59
South Africa
57
Nigeria
55
Uganda
50
Sierra Leone
44
Tanzania
41
Western and Central Europe
41
Nepal
39
Ghana
38
Ethiopia
35
Zambia
35
Myanmar / Burma
35
Liberia
30
Malawi
30
Bangladesh
28
Africa
28
Namibia
27
Eastern Europe
18
South–East Asia Region
17
Lesotho
16
Zimbabwe
14
Cambodia
14
Botswana
13
Latin America and the Carribbean
13
Asia
13
Rwanda
12
Philippines
11
Syria
11
Indonesia
10
Ukraine
10
Congo, Democratic Republic of
9
Russia
8
Cameroon
7
Eswatini/ Swaziland
7
Senegal
6
Pakistan
6
East and Southern Africa
6
West and Central Africa
6
Eastern Europe and Central Asia
6
Tajikistan
6
Burkina Faso
5
South Sudan
5
Thailand
5
Middle East and North Africa
5
Western Pacific Region
5
Albania
5
Mozambique
4
Laos
4
Guinea
3
Iraq
3
Germany
3
Georgia
3
USA
2
Haiti
2
Somalia
2
Afghanistan
2
China
2
Sudan
2
Brazil
2
Sri Lanka
2
Bhutan
2
United Kingdom
2
Jordan
1
Lebanon
1
Turkey
1
Gambia
1
Ireland
1
Singapore
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Serbia
1
Colombia
1
Honduras
1
El Salvador
1
Libya
1
Angola
1
Madagascar
1
Yemen
1
Paraguay
1
Poland
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Vietnam
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
838
Clinical Guidelines
214
Public Health
135
Women & Child Health
94
Key Resources
69
Pharmacy & Technologies
36
Capacity Building
28
Toolboxes
HIV
234
TB
173
AMR
145
Mental Health
127
Pharmacy
74
COVID-19
73
Caregiver
49
Rapid Response
47
NTDs
45
NCDs
41
Ebola
34
Planetary Health
32
Conflict
27
Global Health Education
26
Disability
22
Refugee
21
Cholera
9
Polio
9
Natural Hazards
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
5
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of ...s of integrated surveillance of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
